MTVANasdaqPharmaceutical PreparationsFiscal year ends December 31

MetaVia Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$1.23−0.03 (-2.38%)

Close on Oct 19, 2026

Market cap: $7.30M
P/E (TTM): –
Dividend yield: –

MetaVia Inc. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31
Cash & Equivalents	10	16	22	33	16	10	14	2.85	0.05	24	3.62	0.32	0.00
Cash & Short-Term Investments	10	16	22	33	16	10	14	2.85	0.05	24	3.62	0.32	0.00
Prepaid Expenses & Other	0.60	0.06	0.08	0.17	0.20	0.55	0.15	0.93	0.49	0.71	0.02	–	–
Other Current Assets	–	–	0.06	0.17	–	0.05	0.04	0.03	0.03	–	–	–	–
Total Current Assets	11	16	23	34	17	11	14	3.81	19	25	3.64	–	–
Property, Plant & Equipment	0.02	0.03	0.05	0.00	0.11	0.16	0.20	0.00	–	–	–	–	–
Gross Property, Plant & Equipment	0.09	0.09	0.08	0.03	0.22	0.22	0.22	0.00	–	–	–	–	–
Accumulated Depreciation	-0.07	-0.05	-0.03	-0.03	-0.11	-0.06	-0.02	–	–	–	–	–	–
Operating Lease Right-of-Use Assets	0.21	0.13	0.20	–	0.11	0.13	0.15	0.01	–	–	–	–	–
Other Long-Term Assets	0.02	0.02	0.02	–	–	0.16	0.03	–	–	0.01	–	–	–
Total Assets	11	16	23	34	17	11	14	3.82	19	25	4.49	–	–
Accounts Payable	1.06	3.88	0.82	0.71	0.83	2.58	0.64	0.17	4.03	2.01	0.53	–	–
Accrued Expenses	–	–	4.41	0.28	1.30	1.10	1.42	0.05	1.01	2.11	1.62	–	–
Current Portion of Leases	0.07	0.08	0.07	–	0.03	0.02	0.02	–	–	–	–	–	–
Other Current Liabilities	3.31	1.47	0.79	–	–	–	–	–	–	–	–	–	–
Total Current Liabilities	5.65	8.27	5.96	12	2.16	3.70	2.08	0.22	6.39	4.12	8.92	–	–
Long-Term Leases	0.14	0.06	0.14	–	0.05	0.07	0.09	–	–	–	–	–	–
Operating Lease Liabilities	0.21	0.14	0.20	–	0.07	0.09	0.12	0.07	–	–	–	–	–
Other Long-Term Liabilities	–	–	–	–	–	–	–	0.00	0.00	0.00	–	–	–
Total Liabilities	5.79	8.33	6.10	12	2.20	3.77	2.18	0.36	15	4.12	8.92	–	–
Common Stock	0.00	0.00	0.01	0.03	0.00	0.02	0.02	0.02	0.02	0.02	0.01	–	–
Additional Paid-In Capital	154	144	125	118	96	74	49	2.27	64	48	–	–	–
Retained Earnings	-149	-136	-108	-96	-82	-67	-37	-16	-60	-27	-12	–	–
Comprehensive Income & Other	–	–	–	–	0.00	0.01	0.01	0.00	–	–	–	–	–
Shareholders' Equity	5.33	7.93	17	22	15	7.20	12	-13	0.03	21	-12	-0.53	-0.26
Total Equity	5.33	7.93	17	22	15	7.20	12	-13	0.03	21	-12	-0.53	-0.26
Total Liabilities & Equity	11	16	23	34	17	11	14	3.82	19	25	4.49	–	–
Shares Outstanding(shares)	2.31	0.79	0.45	0.29	0.01	0.01	0.01	0.00	0.00	0.00	0.00	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -195.6%

Financial strength

Current ratio: 2.06
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 199.1%

Valuation

P/E ratio: –
Price to sales: –
Price to book: 1.07
Dividend yield: –